Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Aurinia Pharmaceuticals Inc’s stock clocked out at $5.45, down -0.18% from its previous closing price of $5.46. In other words, the price has decreased by -$0.18 from its previous closing price. On the day, 0.96 million shares were traded. AUPH stock price reached its highest trading level at $5.48 during the session, while it also had its lowest trading level at $5.37.
Ratios:
To gain a deeper understanding of AUPH’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.82 and its Current Ratio is at 5.33. In the meantime, Its Debt-to-Equity ratio is 0.24 whereas as Long-Term Debt/Eq ratio is at 0.19.
Oppenheimer Upgraded its Perform to Outperform on December 10, 2021, whereas the target price for the stock was revised from $33 to $31.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 06 ’24 when Habig Scott Michael sold 18,249 shares for $5.31 per share. The transaction valued at 96,902 led to the insider holds 456,338 shares of the business.
MacKay-Dunn R. Hector sold 5,630 shares of AUPH for $32,316 on May 21 ’24. The Director now owns 18,595 shares after completing the transaction at $5.74 per share. On May 21 ’24, another insider, Leversage Jill, who serves as the Director of the company, sold 5,610 shares for $5.74 each. As a result, the insider received 32,201 and left with 12,918 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AUPH now has a Market Capitalization of 779300992 and an Enterprise Value of 534950816. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.76 while its Price-to-Book (P/B) ratio in mrq is 2.14. Its current Enterprise Value per Revenue stands at 2.583 whereas that against EBITDA is -19.706.
Stock Price History:
Over the past 52 weeks, AUPH has reached a high of $10.24, while it has fallen to a 52-week low of $4.71. The 50-Day Moving Average of the stock is -1.56%, while the 200-Day Moving Average is calculated to be -16.46%.
Shares Statistics:
It appears that AUPH traded 1.32M shares on average per day over the past three months and 1595530 shares per day over the past ten days. A total of 143.83M shares are outstanding, with a floating share count of 128.68M. Insiders hold about 10.01% of the company’s shares, while institutions hold 36.60% stake in the company. Shares short for AUPH as of 1722384000 were 9842138 with a Short Ratio of 7.44, compared to 1719532800 on 10315402. Therefore, it implies a Short% of Shares Outstanding of 9842138 and a Short% of Float of 6.92.
